chevron-down Created with Sketch Beta.

    Jurimetrics Winter 2016

    Volume 56 Issue 2  

    Health

    A Property Theory of Medical Innovation

    ANNA B. LAAKMANN

    In discussions about the proper scope and strength of intellectual property (IP) protection, commentators frequently note that robust IP rights for medical technology developers are necessary to offset the costs of regulatory scrutiny by the U.S. Food and Drug Administration (FDA).

    Featured Articles